MELINTA THERAPEUTICS
Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, whic... h is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus.
MELINTA THERAPEUTICS
Industry:
Biotechnology Emergency Medicine Health Care Pharmaceutical
Founded:
2000-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.melinta.com
Total Employee:
251+
Status:
Active
Contact:
(203) 624-5606
Email Addresses:
[email protected]
Total Funding:
877.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-09 | Tetraphase Pharmaceuticals | Tetraphase Pharmaceuticals acquired by Melinta Therapeutics | N/A |
| 2017-11-29 | The Medicines Company - Infectious Disease Care | The Medicines Company - Infectious Disease Care acquired by Melinta Therapeutics | 270 M USD |
Investors List
CARB-X
CARB-X investment in Grant - Melinta Therapeutics
Deerfield
Deerfield investment in Post-IPO Debt - Melinta Therapeutics
Oberland Capital
Oberland Capital investment in Post-IPO Equity - Melinta Therapeutics
Malin Corporation
Malin Corporation investment in Post-IPO Equity - Melinta Therapeutics
Vatera Healthcare Partners
Vatera Healthcare Partners investment in Post-IPO Equity - Melinta Therapeutics
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Melinta Therapeutics
Falcon Flight
Falcon Flight investment in Post-IPO Equity - Melinta Therapeutics
Vatera Healthcare Partners
Vatera Healthcare Partners investment in Post-IPO Equity - Melinta Therapeutics
ABS Ventures
ABS Ventures investment in Post-IPO Equity - Melinta Therapeutics
Vox Equity Partners I
Vox Equity Partners I investment in Post-IPO Equity - Melinta Therapeutics
Key Employee Changes
Official Site Inspections
http://www.melinta.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.72 K
- Host name: 4.236.191.31
- IP address: 4.236.191.31
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Melinta Therapeutics"
Homepage - Melinta
Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today, ten scientific presentations with data …See details»
About Melinta - Melinta
We are the company of the moment and the enterprise of the future. We can’t wait to make legendary strides. Every step counts. To provide innovative therapies to people impacted by …See details»
Our Impact - Melinta
Melinta’s growing portfolio represents our commitment to providing innovative therapies for acute and life-threatening illnesses. We are unparalleled in our ability to meet the unmet needs of …See details»
Melinta Therapeutics - Wikipedia
Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital settings. The company is located in Parsippany, New Jersey. In mid-2011, Sanofi entered into a global research collaboration and licensing option with the co…See details»
Melinta Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.See details»
Melinta Medical Affairs
Access educational resources to learn about our products and associated disease states, including medical education programs, publications, clinical trials, and reference lab and susceptibility testing information. See ways to contact …See details»
Melinta Therapeutics - LinkedIn
Melinta Therapeutics | 9,282 followers on LinkedIn. Unparalleled in Passion & Purpose | High touch and big impact are trademarks of Melinta.See details»
Melinta Therapeutics' Leadership Team - The Org
Melinta Therapeutics' Leadership Team includes Jennifer Sanfilippo and 8 others.See details»
Melinta Therapeutics Completes Acquisition of The Medicines
Jan 8, 2018 · Melinta Therapeutics, Inc. is the largest pure-play antibiotics company, dedicated to saving lives threatened by the global public health crisis of bacterial infections through the …See details»
Antibiotics maker Melinta emerges from bankruptcy …
Apr 23, 2020 · One of New Haven’s earliest biotechnology companies has emerged from Chapter 11 bankruptcy and has officially handed over ownership to a New York health-care investment firm.See details»
Melinta Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, acquisitions, investors, and executives for Melinta Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Cempra and Melinta Announce Merger to Form Leading, Vertically ...
Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical …See details»
Melinta Subsidiary Corp. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Melinta Subsidiary Corp. of Parsippany, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Melinta Therapeutics to buy The Medicines Company's infectious …
Melinta Therapeutics has agreed to acquire the infectious disease business from The Medicines Company. This includes three marketed products: recently approved and launched Vabomere …See details»
Melinta announces restructuring agreement - BioCT
Melinta Therapeutics has entered into a restructuring support agreement with the lenders pursuant to a pre-negotiated chapter 11 plan of reorganization.See details»
News - Melinta
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announces the appointment of Sunitha …See details»
Our Products - Melinta
We are smart and choiceful about our diverse and expanding portfolio. It’s intentionally focused where patients are in need and bolstered by our strong commercial capabilities. Because that …See details»
Melinta Therapeutics Announces Strategic Realignment and New …
Oct 7, 2013 · Melinta's new strategic direction leverages the Nobel Prize-winning science developed by Rib-X's founders. To accelerate the product portfolio, the Company will be led by …See details»
Antibiotic developer Melinta files for bankruptcy - CIDRAP
Drug maker Melinta Therapeutics today filed for Chapter 11 bankruptcy, becoming the second antibiotic developer this year to be forced into bankruptcy because of financial problems.See details»
Melinta grows pipeline through reverse merger with Cempra
Aug 9, 2017 · Melinta Therapeutics Inc. is headed to the Nasdaq stock exchange armed with a souped-up pipeline courtesy of a reverse merger with a struggling anti-infectives drugmaker. …See details»